BiotechTube
Home/Neuron23/Nancy Stagliano
NS

Nancy Stagliano

CEO

Neuron23

Therapeutic Areas

NeurologyImmunology

Neuron23 Pipeline

DrugIndicationPhase
NEU-411LRRK2-driven Parkinson's DiseasePhase 2